About Us
Submissions
Advertising
SIGN IN
|
SUBSCRIBE
ISSUE
CURRENT
ARCHIVE
SUPPLEMENTS
JADPRO LIVE
2019
JADPRO Live 2018 Activities
JADPRO Live 2017 Activities
CE
RESOURCES
Updates in Heme Malignancy Side Effects
Myeloproliferative Neoplasms Updates
Knowledge Center: Oral Oncolytics
APSHO EMPOWERED
CAREER CENTER
Narratives: HER2-Positive Breast Cancer
QUICK TIPS
HIGHLIGHTS
Main Session:
Advances in Extended Adjuvant HER2-Positive Early Breast Cancer
How do I select patients for treatment with extended adjuvant therapies such as neratinib?
G. Thomas Budd, MD
G. Thomas Budd, MD, on advances in extended adjuvant HER2+ early breast cancer.
Bot trap - Don't go here
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our
Privacy Policy
to learn more.
